Medicine and Dentistry
Neoplasm
100%
Tumor Biopsy
50%
Non Small Cell Lung Cancer
50%
Triage
50%
Drug Resistance
50%
Insulin Pump
50%
Biopsy
40%
Disease
28%
Radiation Oncologist
25%
Overall Survival
21%
Progression Free Survival
21%
Nuclear Medicine Physician
12%
Nocturnal Hypoglycemia
12%
Quality of Life Perception
12%
Lymph Node
10%
Malignant Neoplasm
10%
Tumor Cell
10%
Needle Biopsy
10%
Contrast-Enhanced Ultrasound
10%
Lung Biopsy
10%
Image Guided Biopsy
10%
Cancer Chemotherapy
10%
Liver Biopsy
10%
Target Lesion
10%
Embolization
10%
Patient Characteristics
10%
Necrosis
10%
Tumor Progression
10%
Primary Tumor
10%
Bleeding
10%
Epidermal Growth Factor Receptor
7%
Kaplan Meier Method
7%
Proportional Hazards Model
7%
First-Line Chemotherapy
7%
Liver Metastasis
7%
Brain Metastasis
7%
Metastatic Carcinoma
7%
Survival Rate
7%
Univariate Analysis
7%
Immunology and Microbiology
COVID-19
100%
Immune Response
83%
Antiviral Immunity
50%
Immunity
50%
Severe Acute Respiratory Syndrome Coronavirus 2
45%
Cytotoxic T-Cell
41%
Gross Tumor Volume
37%
Dendritic Cell
29%
Antibody Secreting Cell
29%
Polymerase Chain Reaction
29%
CD4
29%
Immunopathology
29%
T Cell
29%
Immunocompetent Cell
29%
Monospecific Antibody
16%
Interferon Type I
16%
Arm
16%
CXCL10
16%
Antibody Response
16%
T Cell Receptor
12%
T-Helper Cell
12%
Antigen Presenting Cell
12%
Seroconversion
12%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Resistance
50%
Non Small Cell Lung Cancer
50%
Sustained Release
50%
Normal Human
50%
Neoplasm
50%
Flucytosine
50%
Bioavailability
50%
Tablet
50%
Disease
28%
Overall Survival
21%
Progression Free Survival
21%
Chemotherapy
21%
Pharmacokinetics
20%
Physiologically Based Pharmacokinetic Modelling
10%
Pharmacokinetic Parameter
10%
Mycosis
10%
Bioequivalence
10%
HIV
10%
Phase I Trials
10%
Meningoencephalitis
10%
Brain Metastasis
7%
Survival Rate
7%
First-Line Chemotherapy
7%
Epidermal Growth Factor Receptor
7%
Liver Metastasis
7%
